Chimeric chikungunya viruses are nonpathogenic in highly sensitive mouse models but efficiently induce a protective immune response

Journal of Virology

Volumn 85, Issue 17, 2011, Pages 9249-9252

  Wang, Eryu ^a   Kim, Dal Young ^b   Weaver, Scott C ^a   Frolov, Ilya ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; NEUTRALIZING ANTIBODY; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; CELLULAR IMMUNITY; CHEMOSENSITIVITY; CHIKUNGUNYA ALPHAVIRUS; CHIMERA; CONTROLLED STUDY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOCOMPETENCE; INNATE IMMUNITY; MOUSE; NONHUMAN; NOTE; PHENOTYPE; PRIORITY JOURNAL; VACCINATION; VIRUS GENOME; VIRUS RECOMBINANT; VIRUS STRAIN; VIRUS VIRULENCE;

ALPHAVIRUS INFECTIONS; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CHIKUNGUNYA VIRUS; DISEASE MODELS, ANIMAL; MICE; RODENT DISEASES; VACCINES, ATTENUATED; VACCINES, SYNTHETIC; VIRAL VACCINES;

ALPHAVIRUS; CHIKUNGUNYA VIRUS; MUS;

EID: 80052283475     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00844-11     Document Type: Note

References (23)

1. Alevizatos, A. C., R. W. McKinney, and R. D. Feigin. 1967. Live, attenuated Venezuelan equine encephalomyelitis virus vaccine. I. Clinical effects in man. Am. J. Trop. Med. Hyg. 16:762-768.
2. Arankalle, V. A., et al. 2007. Genetic divergence of Chikungunya viruses in India (1963-2006) with special reference to the 2005-2006 explosive epidemic. J. Gen. Virol. 88:1967-1976.
3. Atasheva, S., A. Fish, M. Fornerod, and E. I. Frolova. 2010. Venezuelan equine encephalitis virus capsid protein forms a tetrameric complex with CRM1 and importin alpha/beta that obstructs nuclear pore complex function. J. Virol. 84:4158-4171.
4. Atasheva, S., N. Garmashova, I. Frolov, and E. Frolova. 2008. Venezuelan equine encephalitis virus capsid protein inhibits nuclear import in mammalian but not in mosquito cells. J. Virol. 82:4028-4041.
5. Atasheva, S., V. Krendelchtchikova, A. Liopo, E. Frolova, and I. Frolov. 2010. Interplay of acute and persistent infections caused by Venezuelan equine encephalitis virus encoding mutated capsid protein. J. Virol. 84:10004-10015.
6. Edelman, R., et al. 2000. Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218. Am. J. Trop. Med. Hyg. 62:681-685.
7. Enserink, M. 2006. Infectious diseases. Massive outbreak draws fresh attention to little-known virus. Science 311:1085.
8. Garmashova, N., et al. 2007. Analysis of Venezuelan equine encephalitis virus capsid protein function in the inhibition of cellular transcription. J. Virol. 81:13552-13565.
9. Garmashova, N., R. Gorchakov, E. Frolova, and I. Frolov. 2006. Sindbis virus nonstructural protein nsP2 is cytotoxic and inhibits cellular transcription. J. Virol. 80:5686-5696.
10. Garmashova, N., et al. 2007. The Old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff. J. Virol. 81:2472-2484.
11. Hapuarachchi, H. C., et al. 2010. Re-emergence of Chikungunya virus in South-east Asia: virological evidence from Sri Lanka and Singapore. J. Gen. Virol. 91:1067-1076.
12. Kim, D. Y., et al. 2011. Design of chimeric alphaviruses with a programmed, attenuated, cell type-restricted phenotype. J. Virol. 85:4363-4376.
13. Pittman, P. R., et al. 1996. Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine. Vaccine 14:337-343.
14. Rao, T. R. 1966. Recent epidemics caused by chikungunya virus in India, 1963-1965. Scientific Culture 32:215.
15. Rao, T. R., D. E. Carey, and K. M. Pavri. 1965. Preliminary isolation and identification of chikungunya virus from cases of dengue-like illness in Madras city. Indian J. Med. Res. 53:689-693.
16. Rico-Hesse, R., S. C. Weaver, J. de Siger, G. Medina, and R. A. Salas. 1995. Emergence of a new epidemic/epizootic Venezuelan equine encephalitis virus in South America. Proc. Natl. Acad. Sci. U. S. A. 92:5278-5281.
17. Strauss, J. H., and E. G. Strauss. 1994. The alphaviruses: gene expression, replication, evolution. Microbiol. Rev. 58:491-562.
18. Volkova, E., et al. 2008. IRES-dependent replication of Venezuelan equine encephalitis virus makes it highly attenuated and incapable of replicating in mosquito cells. Virology 377:160-169.
19. Wang, E., et al. 2008. Chimeric alphavirus vaccine candidates for chikungunya. Vaccine. 26:5030-5039.
20. Weaver, S. C., and A. D. Barrett. 2004. Transmission cycles, host range, evolution and emergence of arboviral disease. Nat. Rev. Microbiol. 2:789-801.
21. Weaver, S. C., and I. Frolov. 2005. Togaviruses, p. 1010-1024. In B. W. J. Mahy and V. ter Meulen (ed.), Virology, vol. 2. Hodder Arnold, Salisbury, United Kingdom.
22. Weaver, S. C., et al. 1994. Evolution of alphaviruses in the eastern equine encephalomyelitis complex. J. Virol. 68:158-169.
23. Weaver, S. C., et al. 1996. Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America. VEE Study Group. Lancet. 348:436-440.